Janus Henderson Investors US’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | $1.36M | Sell |
15,476
-12,800
| -45% | -$1.12M | ﹤0.01% | 961 |
|
|
2016
Q4 | $2.34M | Buy |
28,276
+6,276
| +29% | +$520K | ﹤0.01% | 941 |
|
|
2016
Q3 | $2.04M | Sell |
22,000
-1,800
| -8% | -$167K | ﹤0.01% | 952 |
|
|
2016
Q2 | $1.85M | Sell |
23,800
-29,500
| -55% | -$2.3M | ﹤0.01% | 927 |
|
|
2016
Q1 | $4.4M | Sell |
53,300
-389,600
| -88% | -$32.1M | ﹤0.01% | 794 |
|
|
2015
Q4 | $46.4M | Sell |
442,900
-160,900
| -27% | -$16.9M | 0.04% | 448 |
|
|
2015
Q3 | $63.6M | Buy |
603,800
+124,469
| +26% | +$13.1M | 0.06% | 368 |
|
|
2015
Q2 | $65.6M | Buy |
479,331
+205,731
| +75% | +$28.1M | 0.05% | 394 |
|
|
2015
Q1 | $34.1M | Buy |
273,600
+266,000
| +3,500% | +$33.1M | 0.03% | 525 |
|
|
2014
Q4 | $687K | Buy |
7,600
+4,400
| +138% | +$398K | ﹤0.01% | 1000 |
|
|
2014
Q3 | $231K | Buy |
+3,200
| New | +$231K | ﹤0.01% | 1081 |
|
|
2014
Q2 | – | Sell |
-376,706
| Closed | -$25.7M | – | 1090 |
|
|
2014
Q1 | $25.7M | Sell |
376,706
-314,556
| -46% | -$21.5M | 0.02% | 518 |
|
|
2013
Q4 | $48.6M | Sell |
691,262
-60,917
| -8% | -$4.28M | 0.05% | 397 |
|
|
2013
Q3 | $54.3M | Sell |
752,179
-862,010
| -53% | -$62.3M | 0.05% | 353 |
|
|
2013
Q2 | $90.1M | Buy |
+1,614,189
| New | +$90.1M | 0.09% | 249 |
|